Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Helicobacter pylori surface and cell wall components comprise a diverse set of molecules, including peptidoglycan, lipopolysaccharides (LPS), and outer membrane proteins (OMPs), which are vital for the bacterium's survival in the gastric environment [1]. The peptidoglycan layer provides essential structural support and osmotic protection, making it a primary target for beta-lactam antibiotics like amoxicillin, which inhibit the cross-linking of peptidoglycan chains [2]. LPS on the surface often exhibits Lewis antigen mimicry, allowing the pathogen to evade the host's immune system by appearing as self and avoiding complement-mediated killing [4, 5]. Outer membrane proteins, such as BabA and SabA, function as adhesins that bind to gastric epithelial cells, facilitating persistent colonization and the delivery of virulence factors [3]. These surface components are also the focus of vaccine research, as they are the first points of contact with the host immune system and can induce protective antibody responses [1]. Disruption of these components or the inhibition of their synthesis leads to bacterial cell death or reduced virulence, which is the basis for current triple and quadruple therapy regimens [2]. Consequently, these structures are central to the management of H. pylori-related diseases, including chronic gastritis, peptic ulcers, and gastric adenocarcinoma [1].
Inhibition of peptidoglycan synthesis by binding to penicillin-binding proteins (PBPs) and physical disruption of the bacterial cell membrane integrity.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Helicobacter pylori surface and cell wall components.